BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News
Gland Pharma Ltd Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
543245
ISIN Demat
INE068V01023
Book Value (Rs)
656.1222708
NSE Symbol
GLAND
Divident Yield %
0.93
Market Cap
(Rs In Cr.)
35,574
P/E (TTM)
27
EPS (TTM)
79.97
Face Value
(Rs)
1
Date Heading
18-May-26 Nifty trades below 23,400 level; consumer durables shares tumble
18-May-26 Volumes spurt at J K Cements Ltd counter
18-May-26 Gland Pharma spurts as Q4 PAT jumps 97% YoY to Rs 367 crore
18-May-26 Gland Pharma Ltd leads gainers in 'A' group
18-May-26 Benchmarks end marginally higher; Nifty settles near 23,650 mark
18-May-26 Volumes spurt at Gland Pharma Ltd counter
15-May-26 Gland Pharma to hold AGM
15-May-26 Board of Gland Pharma recommends final dividend
15-May-26 Gland Pharma consolidated net profit rises 96.57% in the March 2026 qu
15-May-26 Gland Pharma Q4 PAT jumps 97% YoY to Rs 367 crore
08-May-26 Gland Pharma Ltd gains for third consecutive session
22-Apr-26 Gland Pharma to hold board meeting
06-Mar-26 Gland Pharma Ltd eases for fifth straight session
04-Mar-26 Stock Alert: Adani Ports, Natco Pharma, Gland Pharma, Allied Blenders,
04-Mar-26 Gland Pharma receives USFDA approval for Brimonidine Tartrate Ophthalm
Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)